| Title |
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
|
|---|---|
| Published in |
Journal of Hematology & Oncology, July 2020
|
| DOI | 10.1186/s13045-020-00934-x |
| Pubmed ID | |
| Authors |
Bo Wang, Oliver Van Oekelen, Tarek H. Mouhieddine, Diane Marie Del Valle, Joshua Richter, Hearn Jay Cho, Shambavi Richard, Ajai Chari, Sacha Gnjatic, Miriam Merad, Sundar Jagannath, Samir Parekh, Deepu Madduri |
X Demographics
The data shown below were collected from the profiles of 25 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 11 | 44% |
| Japan | 1 | 4% |
| Spain | 1 | 4% |
| Comoros | 1 | 4% |
| Unknown | 11 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 14 | 56% |
| Scientists | 8 | 32% |
| Practitioners (doctors, other healthcare professionals) | 2 | 8% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 301 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 301 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 41 | 14% |
| Student > Bachelor | 37 | 12% |
| Student > Master | 34 | 11% |
| Other | 19 | 6% |
| Student > Doctoral Student | 16 | 5% |
| Other | 49 | 16% |
| Unknown | 105 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 93 | 31% |
| Nursing and Health Professions | 27 | 9% |
| Biochemistry, Genetics and Molecular Biology | 11 | 4% |
| Psychology | 8 | 3% |
| Agricultural and Biological Sciences | 5 | 2% |
| Other | 35 | 12% |
| Unknown | 122 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 December 2020.
All research outputs
#2,078,152
of 23,221,875 outputs
Outputs from Journal of Hematology & Oncology
#148
of 1,204 outputs
Outputs of similar age
#57,260
of 396,834 outputs
Outputs of similar age from Journal of Hematology & Oncology
#7
of 42 outputs
Altmetric has tracked 23,221,875 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,204 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 396,834 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 42 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.